Country

Merz Products Recognized as Best-In-Class by NewBeauty, THE European Aesthetic Guide and InStyle Magazine

Ultherapy®, Radiesse®, Cellfina® and Neocutis® receive prestigious award

Merz announced today that Ultherapy®, Radiesse® and Cellfina® have been named the best “In-Office Treatments” by NewBeauty Magazine. In addition, Cellfina® was recognized as the “Best Non-Surgical Body Shaping Device” by THE European Aesthetic Guide. Neocutis® Lumière® and Lumière® Riche were named “Best Beauty Buys” by InStyle Magazine.

“These awards demonstrate the high level of patient satisfaction with Merz’s portfolio of treatments and products,” said Bob Rhatigan, CEO of Merz North America. “With our award-winning offerings, physicians are able to address their patients’ needs with trusted technologies that have proven results for the face and body.”

This is the fifth consecutive year Ultherapy® has received a NewBeauty award and was named the “Tried-and-True Skin Tightener” in 2018 for its ultrasound technology that lifts and tightens skin. Cellfina® won for the second year in a row and was named the “Ultimate Cellulite Fighter” for being effective for up to three years. For the first time, Radiesse® was named the “Quick Fix For Better-Looking Hands” for being the only filler FDA-approved to correct lost volume in hands. NewBeauty Magazine readers, as well as renowned beauty experts and editors, made their votes count in the magazine’s eighth annual Beauty Choice Awards, selecting several Merz products from thousands of submissions and hundreds of nominations. The Beauty Choice Awards recognize the industry’s best products.

In addition, Cellfina® was named the “Best Non-Surgical Body Shaping Device” by THE European Aesthetic Guide as part of its second annual industry awards. THE Aesthetic Industry Awards celebrate innovative, cutting-edge technologies, techniques and practices at the forefront of the aesthetic space. Cellfina® was recognized as the only U.S. FDA-cleared and EU CE Mark-certified cellulite treatment that is a minimally invasive, one-time procedure clinically proven to improve the appearance of cellulite for at least three years – the longest duration for a cellulite treatment that targets the primary structural cause of cellulite.

InStyle Magazine named Neocutis® Lumière® and Lumière® Riche “Best Beauty Buys” in 2018, marking the nineteenth time Neocutis® has been awarded the title since 2009. Lumière® received two awards this year for “Best Eye Cream” and “Best Anti-Aging Eye Cream,” and Lumière® Riche won the award for “Best Dry Skin Eye Cream.” Neocutis Lumière® has been honored as an InStyle “Best Beauty Buy” 10 years in a row. This is the second time Lumière® Riche has been honored as the best eye cream for dry skin.

For full product and safety information, including possible mild side effects of Ultherapy, Cellfina® and Radiesse®, visit www.ultherapy.com/IFU, www.cellfina.com/IFU and www.radiesse.com/instructions-for-use-and-patient-guide, respectively.

For additional information on Neocutis®, or to find an authorized Neocutis® skincare provider near you, visit www.neocutis.com.

Press Contact

Merz North America

Emily Browder
Corporate Communications

 

Phone: +1 919.582.8114

Merz in the Americas

Merz has a direct presence in six countries in the Americas, as well as a network of selected professional distribution partners in South and Central America and the Caribbean. Merz in the Americas is headquartered in Raleigh, North Carolina, and has facilities in Mesa, Arizona, Franksville, Wisconsin as well as offices in Toronto, Canada, Mexico City, Bogotá, Colombia, São Paolo, Brazil and Buenos Aires, Argentina.

Merz Worldwide

With approximately 3,000 employees and a direct presence in 28 countries, Merz is a global, family-owned aesthetics and neurotoxin company based in Frankfurt, Germany. Privately held for 110 years, the company is distinguished by its commitment to innovation, long-term perspective and focus on profitable growth. In addition to its comprehensive portfolio of medical aesthetic products in the device, injectable and skincare categories, Merz also develops neurotoxin therapy to treat neurologically-induced movement disorders. In fiscal year 2016/17, Merz generated revenue of EUR 1,092.9 million. More information is available at www.merz.com.

Media Contact – Global

Merz Pharma GmbH & Co. KGaA
Global Corporate Communications
Mariana Smith Bourland
Phone: +49 151 4249 1466
Email: mariana.smith@merz.com

Media Contact – North America

Merz North America, Inc.
Corporate Communications
Emily Browder
Phone: +1 919.582.8114
Email: Emily.Browder@merz.com